Marine Drugs (Dec 2022)

Construction of Glucose-6-Phosphate Dehydrogenase Overexpression Strain of <i>Schizochytrium</i> sp. H016 to Improve Docosahexaenoic Acid Production

  • Yumei Feng,
  • Yuanmin Zhu,
  • Zhendong Bao,
  • Bohan Wang,
  • Tingting Liu,
  • Huihui Wang,
  • Tianyi Yu,
  • Ying Yang,
  • Longjiang Yu

DOI
https://doi.org/10.3390/md21010017
Journal volume & issue
Vol. 21, no. 1
p. 17

Abstract

Read online

Docosahexaenoic acid (DHA) is an important omega-3 polyunsaturated fatty acid (PUFA) that plays a critical physiological role in human health. Schizochytrium sp. is considered an excellent strain for DHA production, but the synthesis of DHA is limited by the availability of nicotinamide adenine dinucleotide phosphate (NADPH). In this study, the endogenous glucose-6-phosphate dehydrogenase (G6PD) gene was overexpressed in Schizochytrium sp. H016. Results demonstrated that G6PD overexpression increased the availability of NADPH, which ultimately altered the fatty acid profile, resulting in a 1.91-fold increase in DHA yield (8.81 g/L) and increased carbon flux by shifting it from carbohydrate and protein synthesis to lipid production. Thus, G6PD played a vital role in primary metabolism. In addition, G6PD significantly increased DHA content and lipid accumulation by 31.47% and 40.29%, respectively. The fed-batch fermentation experiment results showed that DHA production reached 17.01 g/L in the overexpressing G6PD strain. These results elucidated the beneficial effects of NADPH on the synthesis of PUFA in Schizochytrium sp. H016, which may be a potential target for metabolic engineering. Furthermore, this study provides a promising regulatory strategy for the large-scale production of DHA in Schizochytrium sp.

Keywords